Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin, Navelbine, and Herceptin in HER2+ Metastatic Breast Cancer
NCT00670982Phase 2Completed
- Sponsor
- Harold J. Burstein
- Start
- May 2008
- Primary completion
- Dec 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in HER2-positive metastatic breast cancer, sponsored by Harold J. Burstein. Started May 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
HER2-positive metastatic breast cancer
Beyond the preview
Go deeper on NCT00670982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670982.